Media-OutReach Newswire GangaGen Secures additional US$7.9 Million from CARB-X for Pre-clinical Development of Novel Klebicins Targeting Nosocomial Pneumonia caused by Multidrug-resistant Klebsiella pneumoniae
Life & Style Unlocking the secrets of the microbiome: how it impacts health, allergies, disease, and the influence of antibiotics